A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice
Abstract Accumulation of tau protein is a key pathology of age-related neurodegenerative diseases such as Alzheimer's disease and progressive supranuclear palsy. Those diseases are collectively termed tauopathies. Tau pathology is associated with axonal degeneration because tau binds to microtu...
Enregistré dans:
Auteurs principaux: | Tomohiro Onishi, Ryouta Maeda, Michiko Terada, Sho Sato, Takahiro Fujii, Masahiro Ito, Kentaro Hashikami, Tomohiro Kawamoto, Maiko Tanaka |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/67cf6d93ad1a49af82682f07692cec8c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
par: Geraldine Zimmer-Bensch, et autres
Publié: (2021) -
Acta Nº518
par: Banco Central de Chile
Publié: (2019) -
Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies
par: Emily Miyoshi, et autres
Publié: (2021) -
NMR Studies of Tau Protein in Tauopathies
par: Kristine Kitoka, et autres
Publié: (2021) -
Tauopathy and cognitive impairment in experimental diabetes mellitus
par: Mariia V. Matveeva, et autres
Publié: (2017)